Overview A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro Status: Completed Trial end date: 2008-01-01 Target enrollment: Participant gender: Summary Evaluation of post-prandial blood glucose excursions after a standardized meal and pre meal injections of individual doses of the study insulins. Phase: Phase 2 Details Lead Sponsor: BiodelTreatments: InsulinInsulin GlargineInsulin LisproInsulin, Globin Zinc